ストックスクリーナーアプリを入手
0.0111
0.00%
0.00
前日終値:
$0.0111
開ける：
$0.0111
24時間の取引高:
1,322
Relative Volume:
5.10
時価総額：
$N/A
収益：
$547.00K
当期純損益:
$-34.02M
株価収益率:
-0.000237
EPS:
-46.9127
ネットキャッシュフロー:
$-27.11M
1週間 パフォーマンス:
+0.00%
1か月 パフォーマンス:
+0.00%
6か月 パフォーマンス:
-7.50%
1年 パフォーマンス:
+221.67%
1日の値動き範囲:
$0.0111
$0.0111
1週間の範囲:
$0.0111
$0.0111
52週間の値動き範囲:
$0.01
$1.15
Trevena Inc Stock (TRVN) Company Profile
Compare TRVN vs VRTX, REGN, ARGX, ALNY, ONC
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
TRVN
Trevena Inc
|
0.0111 | 0 | 547.00K | -34.02M | -27.11M | -46.91 |
VRTX
Vertex Pharmaceuticals Inc
|
426.00 | 107.87B | 12.32B | 4.34B | 3.19B | 16.86 |
REGN
Regeneron Pharmaceuticals Inc
|
723.92 | 73.63B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
813.96 | 49.42B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
303.11 | 40.20B | 3.71B | 313.75M | 465.38M | 2.2571 |
ONC
Beone Medicines Ltd Adr
|
314.95 | 33.06B | 5.36B | 287.73M | 924.18M | 2.5229 |
Trevena Inc Stock (TRVN) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2021-03-15 | 開始されました | Oppenheimer | Perform |
| 2020-09-14 | 開始されました | Guggenheim | Buy |
| 2020-08-28 | 開始されました | Cantor Fitzgerald | Overweight |
| 2019-05-31 | 再開されました | H.C. Wainwright | Buy |
| 2018-11-05 | ダウングレード | H.C. Wainwright | Buy → Neutral |
| 2018-10-12 | ダウングレード | Needham | Buy → Hold |
| 2018-10-10 | ダウングレード | Jefferies | Buy → Hold |
| 2017-11-08 | 繰り返されました | Needham | Buy |
| 2017-10-16 | ダウングレード | Barclays | Overweight → Equal Weight |
| 2017-10-12 | 繰り返されました | H.C. Wainwright | Buy |
| 2017-05-08 | 繰り返されました | Needham | Buy |
| 2017-02-23 | 繰り返されました | H.C. Wainwright | Buy |
| 2017-02-22 | 繰り返されました | FBR & Co. | Outperform |
| 2017-02-02 | 開始されました | Ladenburg Thalmann | Buy |
| 2017-01-09 | 開始されました | H.C. Wainwright | Buy |
| 2017-01-05 | 開始されました | Oppenheimer | Outperform |
| 2016-05-17 | 繰り返されました | FBR Capital | Outperform |
| 2016-05-17 | 繰り返されました | Needham | Buy |
| 2016-03-29 | 開始されました | FBR Capital | Outperform |
| 2015-09-01 | 繰り返されました | Wedbush | Outperform |
| 2015-08-03 | 開始されました | Brean Capital | Buy |
すべてを表示
Trevena Inc (TRVN) 最新ニュース
Health News Round upopioid pain drugs, Ebola vaccinations in Uganda and much mmore - Devdiscourse
Diabetic Neuropathy Pipeline Set for Significant - openPR.com
Diabetic Neuropathy Pipeline Set for Significant Breakthroughs by 2026 with 20+ Therapies and Robust Clinical Advancements | DelveInsight - Barchart
Polaris Venture Partners V L P Net WorthInsider Trades and Bio as of Apr 22, 2026 - Benzinga
Verastem, Inc. (VSTM) Stock Price, News, Quote & History - Yahoo! Finance Canada
Chronic and Acute Pain Treatment Pipeline Shows Strong Momentum as 180+ Pharma Companies in the Race | DelveInsight - Barchart.com
TherapeuticsMD, Inc. (TXMD) stock price, news, quote and history - Yahoo Finance UK
Trevena (STU:6T4) PB Ratio : (As of Mar. 28, 2026) - gurufocus.com
Europe Stocks: Research Stocks from Europe Stock Market - GuruFocus
Stock List: Research Stocks from Around the World - GuruFocus
SMX (Security Matters) Public Limited CompanyOrdinary Shares (NQ: SMX - The Chronicle-Journal
Wall Street closes lower, as war on Iran fuels inflation worries - marketscreener.com
S&P Closes Out Third Straight Week of Loses | Closing Bell - marketscreener.com
US Stocks Brief: S&P Futures Down 0.25% - marketscreener.com
Elon Musk's SpaceX weighs Nasdaq listing, sources say - marketscreener.com
Celebrity-studded Caliwater bets cactus is next big wave in hydration - Food Dive
Wall Street opens lower as investors weigh Middle East war risks - marketscreener.com
TRVN Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Trump Says Stock Market Hit 53 New Highs on His Watch - marketscreener.com
US software stocks climb as Anthropic announcement sparks relief rally - marketscreener.com
VINC Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
U.S. S&P 500 E-mini and Nasdaq 100 futures flat, Dow futures down 0.1% - marketscreener.com
Wall Street ends higher, lifted by Nvidia and other AI stocks - marketscreener.com
Tg-17 Inc changes corporate name to Our Bond, Inc. - marketscreener.com
Coinshares Updates on Fourth Quarter, Plans $0.33 Dividend Per Share - marketscreener.com
Investor Increases its Stake in Nasdaq - marketscreener.com
Why Arcadium Lithium Shares Are Trading Higher By 28%; Here Are 20 Stocks Moving Premarket - Intellectia AI
Novakand Pharma applies for Nasdaq's approval of continued listing - marketscreener.com
S&P 500, Nasdaq turn negative; S&P down 0.4%, Nasdaq falls 0.9% - marketscreener.com
Braiin Shares to Begin Trading on Nasdaq - marketscreener.com
Columbus Circle Capital Corp II Prices $200 Million Initial Public Offering - marketscreener.com
Sanofi Concludes $2.2 Billion Takeover of Dynavax Technologies - marketscreener.com
Spring Valley Acquisition Corp. IV Prices $200 Million IPO - marketscreener.com
Unique Global Innovative Solutions Corp. (Ugiz) announces intent to pursue Nasdaq uplisting and capital raise - marketscreener.com
Generate Biomedicines Inc announces initial public offering - marketscreener.com
RCI Hospitality Receives Non-Compliance Letter from Nasdaq - marketscreener.com
Earnings Flash (NDAQ) Nasdaq Posts Q4 Revenue $2.80B - marketscreener.com
Chronic and Acute Pain Clinical Trial Pipeline Analysis: - GlobeNewswire
North American Morning Briefing : Nasdaq Futures Rise; Trade Relations, Earnings in Focus -2 - marketscreener.com
Trevena (NASDAQ:TRVN) Share Price Passes Above Fifty Day Moving Average – Should You Sell? - Defense World
Diabetic Neuropathy Clinical Trial Pipeline Gains Momentum: 18+ Companies Lead the Charge in Pioneering New Treatments | DelveInsight - The Manila Times
Diabetic Neuropathy Clinical Trial Pipeline Gains Momentum: - GlobeNewswire
What technical patterns form on Trevena Inc. (6T4) stock chartsJuly 2025 Market Mood & Fast Entry and Exit Trade Plans - bollywoodhelpline.com
Trevena Restructures China Royalty Rights to Exit Debt - The Globe and Mail
Critical Contrast: Ampio Pharmaceuticals (NYSE:AMPE) vs. Trevena (NASDAQ:TRVN) - Defense World
Trevena Signs Assignment and Release Agreement With R-Bridge Investment Four and Jiangsu Nhwa Pharmaceutical - TradingView — Track All Markets
Trevena (NASDAQ:TRVN) Shares Cross Below Fifty Day Moving Average – Here’s What Happened - Defense World
Ray Therapeutics Appoints Scott Braunstein, M.D., as Chairman of the Board of Directors - BioSpace
How Trevena Inc. (6T4) stock valuation compares with sectorQuarterly Portfolio Review & Risk Managed Investment Entry Signals - ulpravda.ru
Analyst Upgrade: How Trevena Inc. (6T4) stock benefits from digital adoptionJuly 2025 Action & Long Hold Capital Preservation Tips - ulpravda.ru
Published on: 2026-01-09 03:04:06 - ulpravda.ru
Trevena Inc (TRVN) 財務データ
収益
当期純利益
現金流量
EPS
0.78%
3.01%
大文字化:
|
ボリューム (24 時間):